Implications of the Stem Cell Veto on Science in the US
September 1st 2006President George W. Bush's recent veto of the bill to expand federal support for embryonic stem cell research will probably not have any long-term devastating effects on the future treatment of Parkinson disease (PD) or Alzheimer disease (AD).
Troubleshooting Mitoxantrone Use in MS: Combo Therapy May Be Way to Go
September 1st 2006The addition of mitoxantrone (Novantrone) to interferon beta-1b (IFN beta-1b, Betaseron) therapy for the treatment of patients with aggressive multiple sclerosis (MS) unresponsive to standard therapy may reduce the number of new enhancing lesions as well as life-threatening risks associated with mitoxantrone therapy.
Ampakines May Reverse Age-Related Memory Loss
September 1st 2006Ampakines, agents that have been shown to enhance memory, appear to trigger endogenous brain-derived neurotrophic factor (BDNF), a natural mechanism in the brain that could restore neuronal viability and synaptic plasticity through increased trophic support.
ChEIs for the AD Continuum: Redefining Treatment Criteria
September 1st 2006Although cholinesterase inhibitors (ChEIs), specifically donepezil (Aricept), galantamine (Reminyl), and rivastigmine (Exelon), are considered first-line treatment for Alzheimer disease (AD), they are not FDA-approved for use in late-stage disease.
How Does Your Practice Compare? A How-To Guide to Practice Benchmarking
September 1st 2006Everyone is talking about the decline in reimbursements and the increase in overhead costs. While most practices are faltering, some are quite successful--that is, they are economically thriving. So what makes the difference?
New Legislative Move in Battle With Psychologists
September 1st 2006Having lost a few battles over state laws allowing psychologists to prescribe drugs in some cases, organized psychiatry is trying a new tactic--this time at the national level--in order to define professional boundaries in scientifically appropriate ways.
Preventing Rehospitalization in Schizophrenia
September 1st 2006Interventions addressing symptom education, service continuity, and daily structure are the most effective in avoiding inpatient stays in patients with schizophrenia who have had multiple hospitalizations, a study in the June issue of The Journal of Nervous and Mental Disease reported.
Parents as Part of the Therapeutic Process in a Child and Adolescent Referral
September 1st 2006While some mental health services for adolescents allow self-referral, many require parental involvement. There is increasing evidence that working with the family and the child is important if only to increase compliance with medication and to tackle any comorbid difficulties.
Novel Methods to Predict Outcome Using Neuroimaging
September 1st 2006Noninvasive brain imaging methods are providing unprecedented views of the structural and functional development and aging of an individual's brain or state of brain pathology. These exciting new may provide novel information relevant to the enhancement of clinical practice.
ADHD in Girls: Wide Range of Negative Sequelae
September 1st 2006Attention-deficit/hyperactivity disorder (ADHD) in girls may be more persistent than originally thought and may also be associated with a variety of behavioral and mental health consequences such as eating disorders, depression, and substance abuse.
Rebels Without a Cause? Adolescents and Their Antiheroes
Adolescents reject their parents’ icons and seek out and empower their own. Antiheroes seem deliberately provocative, assailing almost every social convention of the adult generation, and parents often fear they are leading youth astray.